GNOM.US Global X Genomics & Biotechnology ETF
- Total assets
- 106M
- Expense ratio
- 0.47%
- Dividend yield
- 0.95%
- 1-year return
- +47.51%
- Holdings
- 50
- Since
- 2019
Fund data as reported by the issuer, updated Nov 14, 2026. Total assets are in the fund's base currency.
What does GNOM.US invest in?
- Mostly US stocks (96.0%)
- Largest sector: Healthcare (96.2%)
- Largest region: North America (97.5%)
- Top 3 holdings: 22.8% of the fund
Asset allocation
- US stocks 96.0%
- Non-US stocks 4.7%
Top holdings
- Moderna Inc 12.27%
- 10X Genomics Inc 5.36%
- Twist Bioscience Corp 5.16%
- Guardant Health Inc 5.09%
- Illumina Inc 4.73%
Global X Genomics & Biotechnology ETF performance
Sharpe ratio 0.79- This year
- +45.21%
- 1 year
- +47.51%
- 3 years
- +20.70%
- 5 years
- -5.51%
Volatility 26.3% over 1 year and 30.8% over 3 years. High: expect large swings.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
GNOM.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About Global X Genomics & Biotechnology ETF
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, Genomics & Biotechnology Companies), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
Full fund profileGlobal X Genomics & Biotechnology ETF top holdings
52.5% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Moderna Inc MRNA.US | Healthcare | United States | 12.27% |
| 10X Genomics Inc TXG.US | Healthcare | United States | 5.36% |
| Twist Bioscience Corp TWST.US | Healthcare | United States | 5.16% |
| Guardant Health Inc GH.US | Healthcare | United States | 5.09% |
| Illumina Inc ILMN.US | Healthcare | United States | 4.73% |
| Natera Inc NTRA.US | Healthcare | United States | 4.65% |
| Qiagen NV QGEN.US | Healthcare | United States | 3.87% |
| Bio-Techne Corp TECH.US | Healthcare | United States | 3.81% |
| Vertex Pharmaceuticals Inc VRTX.US | Healthcare | United States | 3.81% |
| Genscript Biotech Corp 1548.HK | Healthcare | Hong Kong | 3.72% |
The 10 largest of 50 holdings.
GNOM.US sector exposure
- Healthcare96.2%
- Technology0.3%
Share of the stocks in the fund.
GNOM.US regional exposure
- North America97.5%
- Europe Developed3.3%
- United Kingdom1.4%
Share of the stocks in the fund.
Company size
Average market cap 17.0B- Mega cap3.7%
- Big cap7.7%
- Medium cap30.2%
- Small cap41.1%
- Micro cap13.1%
Global X Genomics & Biotechnology ETF fund profile
- Fund name
- Global X Genomics & Biotechnology ETF
- Ticker
- GNOM.US
- Exchange
- USA Stocks
- Issuer
- Global X Funds
- Index tracked
- -
- Category
- Healthcare Equity
- Inception date
- Apr 5, 2019
- Trading currency
- USD
- Expense ratio
- 0.47%
- Annual turnover
- 0.2%
About Global X Genomics & Biotechnology ETF
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, Genomics & Biotechnology Companies), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.